Article
Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A
11 Oct 2023
Abstract excerpt
The normally antiviral enzyme APOBEC3A is an endogenous mutagen in human cancer. Its single-stranded DNA C-to-U editing activity results in multiple mutagenic outcomes including signature single-base substitution mutations (isolated and clustered), DNA breakage, and larger-scale chromosomal aberrations. APOBEC3A inhibitors may therefore comprise a unique class of anti-cancer agents that work by blocking...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
